LAURA CARNEVALE: Open Payments
NPI 1962617159 · UTICA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,042 in 26 payments from 10 companies in 2025. Trend: 2023 $403 · 2024 $105 · 2025 $1,042
Food & beverage: $1,042
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 5 | $206 |
| AstraZeneca Pharmaceuticals LP | 5 | $197 |
| GlaxoSmithKline, LLC. | 4 | $167 |
| Electromed, Inc. | 6 | $135 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| Lilly USA, LLC | 1 | $123 |
| Grifols USA, LLC | 1 | $29 |
| GENZYME CORPORATION | 1 | $26 |
| Novo Nordisk Inc | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: Ohtuvayre, NUCALA, SMARTVEST, CAPLYTA, ZEPBOUND, BREZTRI, TEZSPIRE, FASENRA.
Industry payments across NY — which companies pay providers there.
